Immune activation and inflammation in lactating women on combination antiretroviral therapy: role of gut dysfunction and gut microbiota imbalance
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Curated date: 2024/10/02
Curator: Paavni Goyal
Revision editor(s): WikiWorks, Aleru Divine, Paavni Goyal, KateRasheed
Subjects
- Location of subjects
- Zimbabwe
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- HIV - uninfected
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- HIV - infected
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- The HIV-infected group consists of HIV-infected lactating women who were followed up at 6 weeks postpartum.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 48
- Group 1 sample size Number of subjects in the case (exposed) group
- 25
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V5-V6
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Ion Torrent
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- MaAsLin2
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Curated date: 2024/10/02
Curator: Paavni Goyal
Revision editor(s): WikiWorks, Aleru Divine, Paavni Goyal, KateRasheed
Source: Figure 6a
Description: Differentially abundant taxa significantly associated with HIV infection status at 6 weeks postpartum.
Abundance in Group 1: increased abundance in HIV - infected
NCBI | Quality Control | Links |
---|---|---|
Collinsella | ||
Coriobacteriales | ||
Micrococcaceae | ||
Slackia |
Revision editor(s): WikiWorks, Aleru Divine, Paavni Goyal, KateRasheed
Signature 2
Curated date: 2024/10/02
Curator: Paavni Goyal
Revision editor(s): WikiWorks, Aleru Divine, Paavni Goyal, KateRasheed
Source: Figure 6a
Description: Differentially abundant taxa significantly associated with HIV infection status at 6 weeks postpartum.
Abundance in Group 1: decreased abundance in HIV - infected
NCBI | Quality Control | Links |
---|---|---|
Clostridiaceae | ||
Clostridium |
Revision editor(s): WikiWorks, Aleru Divine, Paavni Goyal, KateRasheed
Experiment 2
Curated date: 2024/10/19
Curator:
Revision editor(s):
Subjects
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- The HIV-infected group consists of HIV-infected lactating women who were followed up at 6 months postpartum.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 42
- Group 1 sample size Number of subjects in the case (exposed) group
- 23
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: Figure 6b
Description: Differentially abundant taxa significantly associated with HIV infection status at 6 months postpartum.
Abundance in Group 1: increased abundance in
NCBI | Quality Control | Links |
---|---|---|
Selenomonadaceae |
Revision editor(s): Aleru Divine, WikiWorks
Signature 2
Source: Figure 6b
Description: Differentially abundant taxa significantly associated with HIV infection status at 6 months postpartum.
Abundance in Group 1: decreased abundance in
NCBI | Quality Control | Links |
---|---|---|
Romboutsia | ||
Clostridium |
Revision editor(s): Aleru Divine, WikiWorks
Experiment 3
Curated date: 2024/10/20
Curator:
Revision editor(s):
Subjects
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- The HIV-infected group consists of HIV-infected lactating women who were followed up at 6 weeks postpartum.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 48
- Group 1 sample size Number of subjects in the case (exposed) group
- 25
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Curated date: 2024/10/20
Curator: KateRasheed
Revision editor(s): KateRasheed, Aleru Divine, WikiWorks
Source: Table 3
Description: Differentially abundant taxa in gut microbiota associated with inflammatory and vascular injury biomarkers after stratification by HIV infection status.
Abundance in Group 1: increased abundance in
NCBI | Quality Control | Links |
---|---|---|
Lachnospira eligens | ||
Oxalobacteraceae |
Revision editor(s): KateRasheed, Aleru Divine, WikiWorks
Signature 2
Curated date: 2024/10/21
Curator: KateRasheed
Revision editor(s): KateRasheed, Aleru Divine, WikiWorks
Source: Table 3
Description: Differentially abundant taxa in gut microbiota associated with inflammatory and vascular injury biomarkers after stratification by HIV infection status.
Abundance in Group 1: decreased abundance in
NCBI | Quality Control | Links |
---|---|---|
Weissella |
Revision editor(s): KateRasheed, Aleru Divine, WikiWorks
Experiment 4
Subjects
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- The HIV-infected group consists of HIV-infected lactating women who were followed up at 6 months postpartum.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 42
- Group 1 sample size Number of subjects in the case (exposed) group
- 23
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: Table 3
Description: Differentially abundant taxa in gut microbiota associated with inflammatory and vascular injury biomarkers after stratification by HIV infection status.
Abundance in Group 1: increased abundance in HIV - infected
NCBI | Quality Control | Links |
---|---|---|
Anaerotignum | ||
Butyrivibrio | ||
Catenibacterium | ||
Haemophilus | ||
Lachnospira eligens |
Revision editor(s): Aleru Divine, WikiWorks
Signature 2
Source: Table 3
Description: Differentially abundant taxa in gut microbiota associated with inflammatory and vascular injury biomarkers after stratification by HIV infection status.
Abundance in Group 1: decreased abundance in HIV - infected
NCBI | Quality Control | Links |
---|---|---|
Actinomyces | ||
Actinomycetota | ||
Bacillota | ||
Coprobacillaceae | ||
Coriobacteriaceae | ||
Eggerthella | ||
Fusobacteriaceae | ||
Lactobacillus | ||
Solobacterium | ||
Clostridia UCG.014Clostridia UCG.014 |
Revision editor(s): Aleru Divine, WikiWorks